Share-based Payment Arrangement, Expense of Orthofix Medical Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Orthofix Medical Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Orthofix Medical Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $7,181,000, a 10% increase year-over-year.
  • Orthofix Medical Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $28,639,000, a 0.64% increase year-over-year.
  • Orthofix Medical Inc. annual Share-based Payment Arrangement, Expense for 2024 was $32,455,000, a 9.1% decline from 2023.
  • Orthofix Medical Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35,707,000, a 94% increase from 2022.
  • Orthofix Medical Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18,443,000, a 20% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Orthofix Medical Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $28,639,000 $7,181,000 +$650,000 +10% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $27,989,000 $7,824,000 -$2,135,000 -21% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $30,124,000 $6,469,000 -$2,331,000 -26% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $32,455,000 $7,165,000 +$3,998,000 +126% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025 2024 FY
Q3 2024 $28,457,000 $6,531,000 +$257,000 +4.1% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $28,200,000 $9,959,000 -$3,287,000 -25% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $31,487,000 $8,800,000 -$4,220,000 -32% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $35,707,000 $3,167,000 -$1,755,000 -36% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $37,462,000 $6,274,000 +$1,545,000 +33% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $35,917,000 $13,246,000 +$8,786,000 +197% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $27,131,000 $13,020,000 +$8,688,000 +201% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $18,443,000 $4,922,000 +$960,000 +24% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 $17,483,000 $4,729,000 +$887,000 +23% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $16,596,000 $4,460,000 +$553,000 +14% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $16,043,000 $4,332,000 +$611,000 +16% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $15,432,000 $3,962,000 +$154,000 +4% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q3 2021 $15,278,000 $3,842,000 +$1,000 +0.03% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $15,277,000 $3,907,000 -$792,000 -17% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $16,069,000 $3,721,000 -$138,000 -3.6% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $16,207,000 $3,808,000 -$354,000 -8.5% 01 Oct 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
Q3 2020 $16,561,000 $3,841,000 -$2,003,000 -34% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $18,564,000 $4,699,000 -$1,150,000 -20% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $19,714,000 $3,859,000 -$1,826,000 -32% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $21,540,000 $4,162,000 -$376,000 -8.3% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $21,916,000 $5,844,000 +$583,000 +11% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $21,333,000 $5,849,000 +$634,000 +12% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $20,699,000 $5,685,000 +$1,769,000 +45% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $18,930,000 $4,538,000 +$1,105,000 +32% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $17,825,000 $5,261,000 +$1,629,000 +45% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019 2019 Q3
Q2 2018 $16,196,000 $5,215,000 +$2,539,000 +95% 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019 2019 Q2
Q1 2018 $13,657,000 $3,916,000 +$1,100,000 +39% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q4 2017 $12,557,000 $3,433,000 -$379,000 -9.9% 01 Oct 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
Q3 2017 $12,936,000 $3,632,000 -$4,510,000 -55% 01 Jul 2017 30 Sep 2017 10-Q 29 Oct 2018 2018 Q3
Q2 2017 $17,446,000 $2,676,000 +$763,000 +40% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018 2018 Q2
Q1 2017 $16,683,000 $2,816,000 +$717,000 +34% 01 Jan 2017 31 Mar 2017 10-Q 30 Apr 2018 2018 Q1
Q4 2016 $15,966,000 $3,812,000 +$2,098,000 +122% 01 Oct 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
Q3 2016 $13,868,000 $8,142,000 +$6,242,000 +329% 01 Jul 2016 30 Sep 2016 10-Q 30 Oct 2017 2017 Q3
Q2 2016 $7,626,000 $1,913,000 +$113,000 +6.3% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $7,513,000 $2,099,000 +$299,000 +17% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $7,214,000 $1,714,000 +$63,000 +3.8% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
Q3 2015 $7,151,000 $1,900,000 +$200,000 +12% 01 Jul 2015 30 Sep 2015 10-Q 31 Oct 2016 2016 Q3
Q2 2015 $6,951,000 $1,800,000 +$614,000 +52% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 $6,337,000 $1,800,000 +$613,000 +52% 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2016 2016 Q1
Q4 2014 $5,724,000 $1,651,000 +$98,000 +6.3% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $5,626,000 $1,700,000 +$423,000 +33% 01 Jul 2014 30 Sep 2014 10-Q 03 Nov 2015 2015 Q3
Q2 2014 $5,203,000 $1,186,000 -$308,000 -21% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015 2015 Q2
Q1 2014 $5,511,000 $1,187,000 -$756,000 -39% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015 2015 Q1
Q4 2013 $6,267,000 $1,553,000 +$84,000 +5.7% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $6,183,000 $1,277,000 -$819,000 -39% 01 Jul 2013 30 Sep 2013 10-Q 25 Mar 2014 2013 Q3
Q2 2013 $7,002,000 $1,494,000 +$189,000 +14% 01 Apr 2013 30 Jun 2013 10-Q 24 Mar 2014 2013 Q2
Q1 2013 $6,813,000 $1,943,000 +$510,000 +36% 01 Jan 2013 31 Mar 2013 10-Q/A 24 Mar 2014 2013 Q1
Q4 2012 $6,303,000 $1,469,000 -$1,000 -0.07% 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $6,304,000 $2,096,000 +$799,000 +62% 01 Jul 2012 30 Sep 2012 10-Q 25 Mar 2014 2013 Q3
Q2 2012 $5,505,000 $1,305,000 -$1,067,000 -45% 01 Apr 2012 30 Jun 2012 10-Q 24 Mar 2014 2013 Q2
Q1 2012 $6,572,000 $1,433,000 -$76,000 -5% 01 Jan 2012 31 Mar 2012 10-Q/A 24 Mar 2014 2013 Q1
Q4 2011 $6,648,000 $1,470,000 01 Oct 2011 31 Dec 2011 10-K 31 Mar 2014 2013 FY
Q3 2011 $1,297,000 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012 2012 Q3
Q2 2011 $2,372,000 01 Apr 2011 30 Jun 2011 10-Q 30 Jul 2012 2012 Q2
Q1 2011 $1,509,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1

Orthofix Medical Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $32,455,000 -$3,252,000 -9.1% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025 2024 FY
2023 $35,707,000 +$17,264,000 +94% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
2022 $18,443,000 +$3,011,000 +20% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $15,432,000 -$775,000 -4.8% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $16,207,000 -$5,333,000 -25% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 $21,540,000 +$2,610,000 +14% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $18,930,000 +$6,373,000 +51% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $12,557,000 -$3,409,000 -21% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $15,966,000 +$8,752,000 +121% 01 Jan 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
2015 $7,214,000 +$1,490,000 +26% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $5,724,000 -$543,000 -8.7% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $6,267,000 -$36,000 -0.57% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $6,303,000 -$345,000 -5.2% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 $6,648,000 -$1,490,000 -18% 01 Jan 2011 31 Dec 2011 10-K 31 Mar 2014 2013 FY
2010 $8,138,000 01 Jan 2010 31 Dec 2010 10-K/A 24 Mar 2014 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.